Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,018 across all filing types
Latest filing 2020-03-24 Transaction in Own Shar…
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
20200324 - UCB Programme de rachat d'actions propres 2020_FR Final.pdf
Transaction in Own Shares Classification · 1% confidence The document is a press release dated March 24, 2020, announcing the launch of a 'Programme de rachat d'actions propres' (Share Buyback Program) to cover employee long-term incentive plans. The key action described is the company acquiring its own ordinary shares, up to a maximum of 1.2 million shares. This directly corresponds to the definition of 'Transaction in Own Shares' (POS), which covers share repurchase programs. Although it is a press release, the core subject matter is the transaction itself, making POS a more specific fit than the general RPA or RNS categories.
2020-03-24 French
20200324 UCB Aandelen Inkoop Programma 2020_NED Final.pdf
Transaction in Own Shares Classification · 1% confidence The document is a formal announcement in Dutch regarding the start of a share buyback program ('Aandelen Inkoopprogramma'). It details the purpose (to cover long-term incentive plans), the maximum number of shares (1.2 million), the start date (March 25, 2020), and mentions that updates will be provided according to applicable legislation. A share repurchase or transaction in own shares falls directly under the definition for 'Transaction in Own Shares' (POS). The document is short and serves as an announcement, but the core subject matter is the transaction itself, making POS more specific than RPA or RNS.
2020-03-24 Dutch
200324- Disposal of own shares.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled 'Disposal of own shares' and details transactions where the company disposed of UCB shares OTC following stock option exercises for employees under the Long Term Incentive Program. This directly relates to the company buying back or selling its own shares, which corresponds to the definition of 'Transaction in Own Shares'. The filing type code for this is POS. The document is short and contains specific transaction details, not just an announcement of a report.
2020-03-24 English
200324 - Aliénation d'actions propres.pdf
Transaction in Own Shares Classification · 1% confidence The document title is "Aliénation d'actions propres" (Alienation of own shares) and the content details transactions where UCB SA alienated (sold/issued) its own shares following the exercise of options by personnel, linking these actions to long-term variable remuneration. The table explicitly lists the date, quantity of shares alienated, and price. This directly corresponds to the definition of a report detailing the company buying back or selling its own shares (share repurchase/issuance). This matches the 'Transaction in Own Shares' category (POS). The document is short and appears to be a direct regulatory disclosure, not an announcement of a larger report.
2020-03-24 French
200324- Vervreemding van eigen aandelen.pdf
Share Issue/Capital Change Classification · 1% confidence The document title is "Vervreemding van eigen aandelen" (Disposal of own shares) and the content details the number of UCB shares disposed of (delivered) to employees following option exercises under Long-Term Incentive (LTI) plans. This transaction type, where a company deals with its own shares, specifically relates to share repurchase or issuance activities, although here it is an issuance/delivery related to employee compensation plans. This aligns directly with the definition for 'Transaction in Own Shares' (POS), which covers share repurchase/issuance. The document is a formal announcement dated March 24, 2020, classified as 'gereglementeerde informatie' (regulated information).
2020-03-24 Dutch
200318- Disposal of own shares.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Disposal of own shares" and details transactions where UCB SA/NV disposed of its own shares OTC following employee stock option exercises related to Long Term Incentive Programs. This directly corresponds to the definition of a report concerning the company buying back or selling its own shares. The appropriate filing code is POS (Transaction in Own Shares). The document is short and appears to be a direct regulatory announcement, not an announcement of a larger report, so RPA/RNS is not preferred over the specific POS category.
2020-03-18 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.